NORCURON
VECURONIUM BROMIDE
Approval overview NORCURON is listed in Drugs@FDA under application 018776 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient VECURONIUM BROMIDE Form and strength INJECTABLE;INJECTION - 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORGANON USA INC Submission history Latest submission status date: 2010-11-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview NORCURON is listed in Drugs@FDA under application 018776 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VECURONIUM BROMIDE Form and strength INJECTABLE;INJECTION - 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORGANON USA INC Submission history Latest submission status date: 2010-11-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.